Overview
Hangdi Xu practices practicing medicine in Hangzhou, China.
Their clinical expertise encompasses Lung Adenocarcinoma, Hepatitis B, Cerebral Hypoxia, and Liver Failure.
They are actively involved in clinical research, co-authoring 18 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Hangdi Xu
Is Hangdi Xu a top-rated expert for Lung Adenocarcinoma?
MediFind is an objective health platform that identifies experts based on real-world data. Hangdi Xu is classified as an Experienced expert for Lung Adenocarcinoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Hangdi Xu participate in research or clinical trials?
Yes. Hangdi Xu has published 18 articles and abstracts on conditions like Lung Adenocarcinoma. You can view a list of Hangdi Xu's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Cerebral HypoxiaXu isExperienced. Learn about Cerebral Hypoxia.
- HepatitisXu isExperienced. Learn about Hepatitis.
- Hepatitis BXu isExperienced. Learn about Hepatitis B.
- Liver FailureXu isExperienced. Learn about Liver Failure.
- Lung AdenocarcinomaXu isExperienced. Learn about Lung Adenocarcinoma.